Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-12-002500
Filing Date
2012-02-14
Accepted
2012-02-14 16:17:09
Documents
1
Period of Report
2011-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 5 - edgar.html 5  
1 FORM 5 - edgar.xml 5 15499
  Complete submission text file 0001179110-12-002500.txt   16677
Mailing Address
Business Address 45 HARTWELL AVE LEXINGTON MA 02421 781-274-8200
SYNTA PHARMACEUTICALS CORP (Issuer) CIK: 0001157601 (see all company filings)

EIN.: 000000000
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O SYNTA PHARMACEUTICALS CORP. 45 HARTWELL AVENUE LEXINGTON MA 02421
Business Address
Chen Lan Bo (Reporting) CIK: 0001325711 (see all company filings)

Type: 5 | Act: 34 | File No.: 001-33277 | Film No.: 12610057